Published in J Arrhythm on January 27, 2016
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell (1995) 10.18
Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature (1996) 9.77
K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature (1996) 8.63
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35
Risk stratification in the long-QT syndrome. N Engl J Med (2003) 7.25
Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev (1994) 5.51
Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J (1957) 5.29
Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science (2002) 4.49
Prevalence of the congenital long-QT syndrome. Circulation (2009) 4.32
Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm (2005) 4.21
Clinical practice. Long-QT syndrome. N Engl J Med (2008) 4.05
A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. J Ir Med Assoc (1964) 3.94
[RARE CARDIAC ARRYTHMIAS OF THE PEDIATRIC AGE. II. SYNCOPAL ATTACKS DUE TO PAROXYSMAL VENTRICULAR FIBRILLATION. (PRESENTATION OF 1ST CASE IN ITALIAN PEDIATRIC LITERATURE)]. Clin Pediatr (Bologna) (1963) 3.59
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA (2005) 3.51
Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science (1991) 3.38
Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation (2005) 3.31
Neural KCNQ (Kv7) channels. Br J Pharmacol (2009) 3.20
Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation (2009) 3.11
Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation (2007) 2.88
Sensing voltage across lipid membranes. Nature (2008) 2.66
Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study. Circulation (1999) 2.61
The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat (2009) 2.54
Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A (2007) 2.49
Long QT syndrome: reduced repolarization reserve and the genetic link. J Intern Med (2006) 2.37
Compound mutations: a common cause of severe long-QT syndrome. Circulation (2004) 2.29
Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol (2012) 2.24
Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol (2011) 2.15
Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation (1997) 2.02
Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. Heart Rhythm (2010) 2.00
Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome. J Cardiovasc Electrophysiol (2003) 1.91
Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome. Circulation (2012) 1.89
The conduction pore of a cardiac potassium channel. Nature (1998) 1.86
Charybdotoxin binding in the I(Ks) pore demonstrates two MinK subunits in each channel complex. Neuron (2003) 1.80
KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A (1997) 1.70
Characterization and subcellular localization of KCNQ1 with a heterozygous mutation in the C terminus. J Mol Cell Cardiol (2001) 1.67
The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation (2007) 1.58
Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation (2004) 1.58
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1. J Am Coll Cardiol (2015) 1.52
Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol (2004) 1.51
A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly. EMBO J (2000) 1.48
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation (2005) 1.48
The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit assembly and protein interaction. J Biol Chem (2007) 1.45
Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk. Cardiovasc Res (2000) 1.42
Impaired KCNQ1-KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction underlies the long QT syndrome. Circ Res (2005) 1.42
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm (2013) 1.33
Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome. Circ Arrhythm Electrophysiol (2009) 1.33
Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc (1999) 1.32
Mechanisms of I(Ks) suppression in LQT1 mutants. Am J Physiol Heart Circ Physiol (2000) 1.24
How really rare are rare diseases?: the intriguing case of independent compound mutations in the long QT syndrome. J Cardiovasc Electrophysiol (2003) 1.19
Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs. J Physiol (2013) 1.17
KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death. Clin Genet (2003) 1.16
PKA and PKC partially rescue long QT type 1 phenotype by restoring channel-PIP2 interactions. Channels (Austin) (2010) 1.07
Down-state model of the voltage-sensing domain of a potassium channel. Biophys J (2010) 1.06
Long QT syndrome: ionic basis and arrhythmia mechanism in long QT syndrome type 1. J Cardiovasc Electrophysiol (2000) 1.05
Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1. Circ Res (2011) 1.00
Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels. Circ Res (2011) 0.99
Truncated KCNQ1 mutant, A178fs/105, forms hetero-multimer channel with wild-type causing a dominant-negative suppression due to trafficking defect. FEBS Lett (2004) 0.97
Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. J Mol Diagn (2006) 0.93
New KCNQ1 mutations leading to haploinsufficiency in a general population; Defective trafficking of a KvLQT1 mutant. Cardiovasc Res (2004) 0.92
Molecular basis of the delayed rectifier current I(ks)in heart. J Mol Cell Cardiol (2001) 0.92
The genetics underlying acquired long QT syndrome: impact for genetic screening. Eur Heart J (2015) 0.89
Recent molecular insights from mutated IKS channels in cardiac arrhythmia. Curr Opin Pharmacol (2013) 0.84
Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome. Cardiovasc Res (2005) 0.83
Slow delayed rectifier potassium current blockade contributes importantly to drug-induced long QT syndrome. Circ Arrhythm Electrophysiol (2013) 0.83
A molecular mechanism for adrenergic-induced long QT syndrome. J Am Coll Cardiol (2013) 0.83
A long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation. PLoS One (2014) 0.81
Third trimester fetal heart rate predicts phenotype and mutation burden in the type 1 long QT syndrome. Circ Arrhythm Electrophysiol (2015) 0.81
Long QT 1 mutation KCNQ1A344V increases local anesthetic sensitivity of the slowly activating delayed rectifier potassium current. Anesthesiology (2006) 0.81
Long QT mutations at the interface between KCNQ1 helix C and KCNE1 disrupt I(KS) regulation by PKA and PIP₂. J Cell Sci (2014) 0.80
High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation. Biochemistry (2012) 0.79
Cellular mechanisms underlying the increased disease severity seen for patients with long QT syndrome caused by compound mutations in KCNQ1. Biochem J (2014) 0.78
LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms. Cardiovasc Res (2014) 0.77
Long-QT mutation p.K557E-Kv7.1: dominant-negative suppression of IKs, but preserved cAMP-dependent up-regulation. Cardiovasc Res (2014) 0.77
Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability. Biochim Biophys Acta (2011) 0.77
A Common Mutation of Long QT Syndrome Type 1 in Japan. Circ J (2015) 0.76
Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1. J Mol Cell Cardiol (2009) 0.76
Cellular mechanisms of mutations in Kv7.1: auditory functions in Jervell and Lange-Nielsen syndrome vs. Romano-Ward syndrome. Front Cell Neurosci (2015) 0.75